Press Releases
Filter By Year
2020
-
September 04, 2020
Kite Submits Supplemental Biologics License Application to U.S. Food and Drug Administration for Yescarta® in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas -
September 03, 2020
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia
-
April 30, 2020
Gilead Sciences Announces First Quarter 2020 Financial Results -
April 21, 2020
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on Natural Killer (NK) Cells -
April 02, 2020
Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma
Filter By Year